0001628280-24-043338.txt : 20241023 0001628280-24-043338.hdr.sgml : 20241023 20241022205326 ACCESSION NUMBER: 0001628280-24-043338 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 18 CONFORMED PERIOD OF REPORT: 20241017 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20241023 DATE AS OF CHANGE: 20241022 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HeartBeam, Inc. CENTRAL INDEX KEY: 0001779372 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 474881450 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41060 FILM NUMBER: 241387617 BUSINESS ADDRESS: STREET 1: 2118 WALSH AVE., SUITE 210 CITY: SANTA CLARA STATE: CA ZIP: 95050 BUSINESS PHONE: 408-899-4443 MAIL ADDRESS: STREET 1: 2118 WALSH AVE., SUITE 210 CITY: SANTA CLARA STATE: CA ZIP: 95050 8-K 1 beat-20241017.htm 8-K beat-20241017
0001779372FALSE00017793722024-10-172024-10-170001779372us-gaap:CommonClassAMember2024-10-172024-10-170001779372us-gaap:WarrantMember2024-10-172024-10-17

  
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
 
Pursuant to Section 13 or 15(d) of the Securities and Exchange Act of 1934
 
Date of Report (Date of earliest event reported): October 17, 2024
 
HEARTBEAM, INC.
(Exact name of Registrant as specified in its charter)
 
Delaware 001-41060 47-4881450
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
 
2118 Walsh Avenue, Suite 210
Santa Clara, CA 95050
(Address of principal executive offices, including zip code)
 
(408) 899-4443
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the 8-K filing is intended to simultaneously satisfy the filing obligations of the registrant under any of the following provisions:
 
☐Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
  
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
  
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
  
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)).
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock
 
BEAT
 
NASDAQ
Warrant
BEATW
NASDAQ
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
 
Emerging growth company ☒
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ 





Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

Appointment of New Chief Executive Officer

On October 17, 2024, the Board of Directors (the “Board”) of HeartBeam, Inc. (the “Company”) appointed Robert Eno as Chief Executive Officer of the Company (the “CEO Appointment”) effective as of October 21, 2024. In connection with the CEO Appointment, the Company entered into an employment agreement with Mr. Eno dated October 15, 2024, (the “CEO Employment Agreement”).

Pursuant to the CEO Employment Agreement, the Company will compensate Mr. Eno an annual fee of $400,000, which is to be paid in semi-monthly installments in accordance with the Company’s normal payroll procedures. Mr. Eno’s salary will be subject to adjustment pursuant to the Company's employee compensation policies in effect from time to time and he will also be eligible to receive certain employee benefits. Additionally, Mr. Eno may receive an incentive bonus of 60% of his annual base salary determined by an agreed to set of corporate goals and objectives. In 2025, the Compensation Committee of the Board will do a full review of equity ownership, with the intent to establish long-term incentives for the role that align to peer group benchmarks and are in line with increasing shareholder value.

This CEO Employment Agreement amends the previous employment agreement executed by Mr. Eno and the Company on January 18, 2023. Except as expressly modified and set forth in the CEO Employment Agreement, all the other terms and conditions of the previous employment agreement shall remain in full force and effect.

Mr. Eno, age 57, has over 30 years of experience creating go-to-market strategies for multiple breakthrough products including noninvasive FFRCT for diagnosing coronary artery disease, laser cataract surgery, scanning retinal laser photocoagulation, and intravascular brachytherapy. He joined HeartBeam as President in January 2023 and will lead as the Company continues to work towards securing the foundational FDA 510(k) clearance for its vector-based technology and prepares for commercialization and growth.

Before joining HeartBeam, Mr. Eno was Chief Executive Officer of Preview Medical, a diagnostic equipment company creating a new category of real-time, in vivo tissue classification for solid tumor cancers, using machine learning and proprietary optical signals. Previously, he was Senior Vice President of Marketing for HeartFlow, leading all aspects of the marketing and product functions for a new category of personalized, noninvasive testing for heart disease, including its initial product, HeartFlow FFRCT. He has also held senior marketing and sales leadership roles at OptiMedica, NeoGuide Systems and Avantec Vascular. Mr. Eno holds an MBA from the Stanford Graduate School of Business and a BA, with Honors and Distinction, from Stanford University, where he was Phi Beta Kappa.

Appointment of New President

On October 17, 2024, the Board appointed Branislav Vajdic, PhD, Founder and current Chief Executive Officer as President of the Company (the “President Appointment”) effective as of October 21, 2024. In connection with the President Appointment, the Company entered into an employment agreement with Dr. Vajdic dated October 17, 2024, (the “President Employment Agreement”).

Pursuant to the President Employment Agreement, there will be no changes to Dr. Vajdic’s current compensation structure. This President Employment Agreement amends the previous employment agreement executed by Dr. Vajdic and the Company on September 19, 2021. Except as expressly modified and set forth in the President Employment Agreement, all the other terms and conditions of the previous employment agreement, shall remain in full force and effect.

As part of the long-planned transition, Dr. Branislav Vajdic will move into the role of President. In this role, he will focus on further innovating the Company’s groundbreaking vector-based technology, driving research and development efforts, and advancing artificial intelligence (AI) applications.






Dr. Vajdic, 70, combines over 30 years of experience in technology development and senior management positions. Dr. Vajdic has been deeply involved with the development of HeartBeam’s technology to fit his vision for the Company. Prior to HeartBeam from 2007 to 2010, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded company in the cardiovascular devices space, from 1984 to 2007, Dr. Vajdic was at Intel, where he held various senior management positions. At Intel, Dr. Vajdic was the designer of first Flash memory and two key inventions that enabled Flash as a product and led engineering groups responsible for Pentium 1 through Pentium 4 designs. Dr. Vajdic was awarded two Intel Achievement Awards, the highest level of award for outstanding contributions to Intel. Dr. Vajdic is author of numerous patents and publications in the fields of cardiovascular devices as well as chip design. Dr. Vajdic holds a PhD degree in Electrical Engineering from the University of Minnesota.

Family Relationships

Neither Mr. Eno nor Dr. Vajdic have a family relationship with any of the current officers or directors of the Company.

Related Party Transactions

There are no related party transactions with regard to Mr. Eno or Dr. Vajdic reportable under Item 404(a) of Regulation S-K.

The foregoing contains only a brief description of the material terms of and does not purport to be a complete description of the rights and obligations of the parties to the CEO Employment Agreements and President Employment Agreement, and such description is qualified in its entirety by reference to the full text of the CEO Employment Agreements and President Employment Agreement, which are filed hereto as Exhibits 10.2 and 10.3 respectively and incorporated herein by reference.

Item 7.01 Regulation FD Disclosure.

On October 17, 2024, the Company issued a press release announcing the appointments. A copy of the press release is filed hereto as Exhibit 99.1 and is incorporated herein by reference.

The information set forth under this Item 7.01 is furnished pursuant to Item 7.01 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section, nor shall it be incorporated by reference into any registration document or other document filed by the Company.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

Exhibit
Number
Description
104Cover Page Interactive Data File (embedded within the Inline XBRL document).
10.2
10.2
99.1


SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
 
 HeartBeam, Inc.
   
Date: October 22, 2024By:/s/ Timothy Cruickshank
 Name: Timothy Cruikshank
 Title:Chief Financial Officer
 
 
 
 



 EX-10.2 2 heartbeambranislavvajdicem.htm EX-10.2 Document

HEARTBEAM, INC.
October 17, 2024

Branislav Vajdic
[Address]


Dear Branislav,
This employment agreement amendment (the “Agreement”) amends your employment agreement executed September 19, 2021 (the “Original Employment Agreement”). All capitalized terms used herein that are not defined herein shall have the definitions set forth in the Original Employment Agreement.
We are pleased to offer you the position of President for HeartBeam Inc. effective October 21, 2024.
There will be no change to your current compensation.
Except as expressly modified and set forth in this Agreement, all of the other terms and conditions of the Original Employment Agreement, shall remain in full force and effect.
We are excited to have you continue in this key role to help drive the organization to execute to its full potential.
Sincerely,

Rich Ferrari
Executive Chairman

Agreed to and accepted:
Signature:
Printed Name: Branislav Vajdic
Date:

 EX-10.2 3 heartbeamrobenoemploymenta.htm EX-10.2 Document

HEARTBEAM, INC.
October 14, 2024

Robert P. Eno
[Address]

Dear Rob,

This employment agreement amendment (the “Agreement”) amends your employment agreement executed January 18, 2023 (the “Original Employment Agreement”). All capitalized terms used herein that are not defined herein shall have the definitions set forth in the Original Employment Agreement.

We are pleased to offer you the position of Chief Executive Officer for HeartBeam Inc. In this capacity, you will be asked to fulfill an important role for the company as it transitions into its preparations for commercial launch and seeks additional financing. In conjunction with the Board of Directors, you will be responsible for the leadership of all strategic, commercial, financial, operational, and human capital functions of HeartBeam. We believe that you will bring such skills to the table and fulfill the most important criteria determined by the board for the company’s next CEO:

•Strong organizational leader from the medical technology industry who can take the company from a technically driven one to successful commercial implementation.
•Visionary leader who can generate excitement among medical practitioners in the market and among investors by clearly articulating the benefit of a disruptive new technology that is clearly distinct from traditional ambulatory cardiac monitors and wearables.
•Experience with leadership within a public company and all the reporting and regulatory requirements/restrictions thereof.

In this new role, your direct reports will be the executive leadership team:
•Branislav Vajdic, President
•Tim Cruickshank, CFO
•Sr, VP Product, Richa Gujarati
•VP Clinical, Pooja Chaterjee
•VP Reg/Quality, Debbie Castillo
•Executive Assistant, Gail Prince
•Chief Medical Officer, Peter FItzgerald









Your compensation will be as follows:

•You will receive an annual salary of $400,000, commencing on October 21, 2024. The salary will be paid semi-monthly in accordance with the Company’s normal payroll procedures. This salary will be subject to adjustment pursuant to the Company’s employee compensation policies in effect from time to time.
•You will be eligible to participate in the Company’s Annual Objectives and Bonus Program. Your bonus target will be set at 60% of your base salary. Any bonus awarded to you pursuant to the program will be payable as soon as practicable after it is earned, but in no event later than March 15 of the year following the year in which the bonus is earned.
•As discussed, following the next financing and at the beginning of 2025, the Compensation Committee will do a full review of equity ownership. It is the company’s intent to develop a plan for Long Term Incentives that match Peer Group Comparables and is line with increasing shareholder value.
•Your severance period will increase from six (6) months to nine (9) months.
•All shares subject to the Option shall accelerate and vest in full if, following a Change in Control, you are either terminated by the Company or you resign with Good Reason.

Except as expressly modified and set forth in this Agreement, all of the other terms and conditions of the Original Employment Agreement, shall remain in full force and effect.

Let us reiterate how excited we are to offer you this key role and to see you drive the organization to execute to its full potential.

Sincerely,

Rich Ferrari
Executive Chairman

Agreed to and accepted:
Signature:
Printed Name: Robert P. Eno
Date:
    



    

EX-99.1 4 heartbeamceopressrelease_1.htm EX-99.1 Document


Exhibit 99.1
image_0.jpg

HeartBeam Appoints Robert Eno as Chief Executive Officer in Preparation for US Commercialization

•Industry leader brings extensive experience in developing go-to-market strategies for breakthrough products and delivering growth

•Founder and current CEO Branislav Vajdic named President to focus on advancing the Company’s groundbreaking vector-based technology for heart health, including AI applications.

SANTA CLARA, Calif.--(BUSINESS WIRE)-- HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful insights wherever the patient is, announced that Robert Eno has been appointed Chief Executive Officer (CEO), effective Monday, October 21, 2024. The seasoned MedTech executive joined HeartBeam as President in January 2023 and will lead as the Company continues to work towards securing the foundational FDA 510(k) clearance for its vector-based technology and prepares for commercialization and growth.

As part of the long-planned transition, Branislav Vajdic, Ph.D., Founder and current CEO, will move into the role of President. In this role, Dr. Vajdic will focus on further innovating on the Company’s groundbreaking vector-based technology, driving research and development efforts, and advancing artificial intelligence (AI) applications.

“HeartBeam is at an important inflection point and the transition comes at the right time where we can best leverage the unique strengths of each leader. Branislav’s commitment to innovation and vision of providing unprecedented cardiac insights has enabled the Company to reach this pivotal point and we will continue to benefit from his drive to unlock the transformative opportunities ahead. Likewise, Rob has spent his career growing companies with innovative technologies, based on his keen understanding of sales, strategic marketing and go-to-market strategies, while maximizing value for stakeholders, and I am confident that his deep experience will ensure the Company is well positioned for success,” said Rich Ferrari, Executive Chairman, Board of Directors, HeartBeam.

HeartBeam’s core vector-based technology captures the heart’s electrical signals from three dimensions to provide total heart intelligence. The Company’s first application of the technology is a cable-free, credit card-sized device that is designed to be capable of synthesizing a 12-lead ECG. The HeartBeam system is currently under review with the FDA. The Company has 13 issued U.S. patents and 4 issued international patents supporting the underlying technology.

“The HeartBeam technology is truly transformative and stands to change how cardiac care is managed in the future. We’ve only scratched the surface of unlocking new insights and understanding how our data-rich signals can benefit physicians and patients,” commented Mr. Eno. “I am honored to lead the Company at this exciting time and look forward to my continued partnership with Branislav as we evolve our business and technology to deliver on strategic objectives.”

With over 30 years of experience, Mr. Eno, age 57, is a passionate leader who has created go-to-market strategies for multiple breakthrough products including noninvasive FFRCT for diagnosing coronary artery disease, laser cataract surgery, scanning retinal laser photocoagulation, and intravascular brachytherapy. Before joining HeartBeam, Mr. Eno was Chief Executive Officer of Preview Medical, a diagnostic equipment company creating a new category of real-time, in vivo tissue classification for solid tumor cancers, using machine learning and proprietary optical signals. Previously, he was Senior Vice


President of Marketing for HeartFlow, leading all aspects of the marketing and product functions for a new category of personalized, noninvasive testing for heart disease, including its initial product, HeartFlow FFRCT. He has also held senior marketing and sales leadership roles at OptiMedica, NeoGuide Systems and Avantec Vascular. Mr. Eno holds an MBA from the Stanford Graduate School of Business and a BA, with Honors and Distinction, from Stanford University, where he was Phi Beta Kappa.

About HeartBeam, Inc.

HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming cardiac care by providing powerful cardiac insights wherever the patient is. The Company is creating the first ever cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions. This platform technology is designed to be used in portable devices that can be used wherever the patient is to deliver actionable heart intelligence. Physicians will be able to identify cardiac health trends and acute conditions and direct patients to the appropriate care – all outside of a medical facility, thus redefining the future of cardiac health management. The Company holds 13 US and 4 international issued patents related to technology enablement.

For additional information, visit HeartBeam.com.

Forward-Looking Statements

All statements in this release that are not based on historical fact are "forward-looking statements." While management has based any forward-looking statements included in this release on its current expectations, the information on which such expectations were based may change. Forward-looking statements involve inherent risks and uncertainties which could cause actual results to differ materially from those in the forward-looking statements, as a result of various factors including those risks and uncertainties described in the Risk Factors and in Management’s Discussion and Analysis of Financial Condition and Results of Operations sections of our Forms 10-K, 10-Q and other reports filed with the SEC and available at www.sec.gov. We urge you to consider those risks and uncertainties in evaluating our forward-looking statements. We caution readers not to place undue reliance upon any such forward-looking statements, which speak only as of the date made. Except as otherwise required by the federal securities laws, we disclaim any obligation or undertaking to publicly release any updates or revisions to any forward-looking statement contained herein (or elsewhere) to reflect any change in our expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based.

Investor Relations Contact: Chris Tyson Executive Vice President MZ North America Direct: 949-491-8235 BEAT@mzgroup.us www.mzgroup.us

Media Contact: media@heartbeam.com




 EX-101.SCH 5 beat-20241017.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 6 beat-20241017_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 7 beat-20241017_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Domain] Class of Stock [Domain] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entities [Table] Entities [Table] Class of Stock [Axis] Class of Stock [Axis] Security Exchange Name Security Exchange Name Warrant Warrant [Member] Entity Ex Transition Period Entity Ex Transition Period Entity Address, City or Town Entity Address, City or Town Soliciting Material Soliciting Material Cover [Abstract] City Area Code City Area Code Amendment Flag Amendment Flag Entity Tax Identification Number Entity Tax Identification Number Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Pre-commencement Tender Offer Pre-commencement Tender Offer Entity Emerging Growth Company Entity Emerging Growth Company Entity Central Index Key Entity Central Index Key Entity File Number Entity File Number Entity Address, State or Province Entity Address, State or Province Common Class A Common Class A [Member] Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Entity Address, Address Line One Entity Address, Address Line One Entity Address, Postal Zip Code Entity Address, Postal Zip Code Written Communications Written Communications Entity Address, Address Line Two Entity Address, Address Line Two Local Phone Number Local Phone Number Title of 12(b) Security Title of 12(b) Security Document Period End Date Document Period End Date Entity Information [Line Items] Entity Information [Line Items] Document Type Document Type EX-101.PRE 8 beat-20241017_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 9 image_0.jpg begin 644 image_0.jpg MB5!.1PT*&@H -24A$4@ >@ !;" 8 "X>19C 7-21T( KLX< MZ0 1G04U! "QCPO\804 )<$A9

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end XML 11 R1.htm IDEA: XBRL DOCUMENT v3.24.3
Cover Page
Oct. 17, 2024
Entity Information [Line Items]  
Document Type 8-K
Document Period End Date Oct. 17, 2024
Entity Registrant Name HEARTBEAM, INC.
Entity Incorporation, State or Country Code DE
Entity File Number 001-41060
Entity Tax Identification Number 47-4881450
Entity Address, Address Line One 2118 Walsh Avenue
Entity Address, Address Line Two Suite 210
Entity Address, City or Town Santa Clara
Entity Address, State or Province CA
Entity Address, Postal Zip Code 95050
City Area Code 408
Local Phone Number 899-4443
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001779372
Amendment Flag false
Common Class A  
Entity Information [Line Items]  
Title of 12(b) Security Common Stock
Trading Symbol BEAT
Security Exchange Name NASDAQ
Warrant  
Entity Information [Line Items]  
Title of 12(b) Security Warrant
Trading Symbol BEATW
Security Exchange Name NASDAQ

EXCEL 12 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 13 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 14 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 16 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.3 html 3 24 1 false 2 0 false 0 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.heartbeam.com/role/CoverPage Cover Page Cover 1 false false All Reports Book All Reports beat-20241017.htm beat-20241017.xsd beat-20241017_def.xml beat-20241017_lab.xml beat-20241017_pre.xml http://xbrl.sec.gov/dei/2024 true false JSON 18 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "beat-20241017.htm": { "nsprefix": "beat", "nsuri": "http://www.heartbeam.com/20241017", "dts": { "inline": { "local": [ "beat-20241017.htm" ] }, "schema": { "local": [ "beat-20241017.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "definitionLink": { "local": [ "beat-20241017_def.xml" ] }, "labelLink": { "local": [ "beat-20241017_lab.xml" ] }, "presentationLink": { "local": [ "beat-20241017_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 2, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 31, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 27 }, "report": { "R1": { "role": "http://www.heartbeam.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "beat-20241017.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "beat-20241017.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Domain]", "label": "Class of Stock [Domain]" } } }, "auth_ref": [] }, "us-gaap_CommonClassAMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "CommonClassAMember", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Common Class A", "label": "Common Class A [Member]" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntitiesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitiesTable", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entities [Table]", "label": "Entities [Table]", "documentation": "Container to assemble all relevant information about each entity associated with the document instance" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line Two", "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInformationLineItems", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Information [Line Items]", "label": "Entity Information [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Class of Stock [Axis]", "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_WarrantMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "WarrantMember", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Warrant", "label": "Warrant [Member]" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://www.heartbeam.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 19 0001628280-24-043338-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-24-043338-xbrl.zip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beat-20241017_htm.xml IDEA: XBRL DOCUMENT 0001779372 2024-10-17 2024-10-17 0001779372 us-gaap:CommonClassAMember 2024-10-17 2024-10-17 0001779372 us-gaap:WarrantMember 2024-10-17 2024-10-17 0001779372 false 8-K 2024-10-17 HEARTBEAM, INC. DE 001-41060 47-4881450 2118 Walsh Avenue Suite 210 Santa Clara CA 95050 408 899-4443 false false false false Common Stock BEAT NASDAQ Warrant BEATW NASDAQ true false